Beckman Coulter Diagnostics, Brea, Calif, and Copan Group, Murrieta, Calif, have amended their existing distribution agreement, expanding their relationship into new products and geographic territories.

Stefania Triva, Copan Group.

Stefania Triva, Copan Group.

The amendment allows Beckman Coulter to distribute Copan’s C-Tracer, SynapsePro Mini, MALDI-Trace, and WaspLab laboratory systems. WaspLab is a digital microbiology system featuring front-end robotic specimen processing, smart incubators, and state-of-the-art image acquisition technology, for full lab automation.

The amended agreement grants Beckman Coulter distribution rights in 21 global markets in Europe, North America, South America, and Asia—including, among other territories, Japan and China.


Arnd Kaldowski, Beckman Coulter Diagnostics.

“We’re very excited to expand our relationship with Copan to offer clinical microbiology laboratories an extended portfolio of products to help provide physicians with the critical information they need regarding bacteria resistance,” says Arnd Kaldowski, president of Beckman Coulter Diagnostics. “Copan’s products complement our newly acquired MicroScan brand of microbiology solutions, and offer hospitals and private laboratories a complete solution which streamlines workflow, demonstrating Beckman Coulter’s commitment to growth and investment in this new area of our business.”

“This is a new step in the collaboration between the two companies, and we look forward to continue working together to expand our reach,” says Stefania Triva, chief executive of Copan Group.

Norman Sharples, Copan Group.

Norman Sharples, Copan Diagnostics.

“Copan has always been committed to provide open platform solutions to our customers,” adds Norman Sharples, executive vice president and cofounder of Copan Diagnostics Inc. “This partnership is further evidence and reinforcement of our ability to integrate and interface with important platforms in microbiology.”

For more information, visit Beckman Coulter Diagnostics or Copan.